Everspin (MRAM) Q1 2026 earnings review
Blockbuster Defense Contract Fuels Acceleration, but Litigation Derails OpEx
Everspin's Q1 2026 marks a structural shift in its growth trajectory. The company reported a 13% YoY revenue increase, driven entirely by a 28% surge in MRAM product sales. More importantly, management announced a massive $40M US prime contractor award and a new Microchip Foundry Services Agreement. However, the bottom line tells a messier story: GAAP operating expenses spiked 22% YoY due to a sudden $1.6M litigation charge, plunging the GAAP operating margin to -18.3%. Despite the near-term profitability hit, the Q2 guidance implies accelerating revenue growth nearing 21% YoY at the midpoint, and that excludes the upcoming $40M contract pipeline.
🐂 Bull Case
The new $40M defense contract is transformational. At roughly 2.5x Everspin's typical quarterly revenue, it significantly de-risks the medium-term outlook and validates the mission-critical value of its SOTA MRAM process technology.
MRAM product sales grew 28% YoY to $14.1M, successfully offsetting a steep decline in lumpy licensing revenue. This indicates strong underlying volume demand across Industrial Automation, Transportation, and Data Center end-markets.
🐻 Bear Case
GAAP operating margin dropped to -18.3%, the worst level in over a year. While heavily distorted by a $1.6M litigation charge, rising R&D and SG&A expenses will pressure cash flows.
Despite a revenue beat and strong top-line Q2 guidance, Q2 GAAP net loss per share is guided at $(0.12) to $(0.07)—a severe deterioration compared to Q1's $(0.01) and prior-year levels.
⚖️ Verdict: 🟢
Bullish. The near-term margin deterioration and litigation noise are frustrating, but securing a $40M defense contract and a Microchip Foundry Agreement fundamentally elevates Everspin's revenue floor and long-term earnings potential.
Key Themes
$40M Defense Contract Changes the Math
Everspin secured a $40M contract with a US prime contractor for State of the Art (SOTA) MRAM process technology and engineering services. This validates the company's strategic push into aerospace and defense and provides a massive, multi-year revenue tailwind. Notably, Q2 guidance of $15.5M-$16.5M explicitly excludes any impact from this new agreement, suggesting further upside revisions as the contract ramps.
Japan Destocking Reversing to Growth
A key drag on 2025 results was inventory bloat in industrial channels. Management explicitly noted that the destocking phase is ending, particularly citing a recovery in customer demand in Japan. This provides a clear path for Reversing the cyclical headwinds that plagued the industrial automation segment in early 2025.
Litigation Costs Wreck GAAP Margins
Operating expenses jumped from $8.7M a year ago to $10.6M. The primary culprit was a sudden $1.6M litigation charge booked in Q1 2026. This caused GAAP Operating Margin to fall to -18.3%. Until management clarifies the nature and expected duration of this litigation, investors must treat it as an ongoing risk to profitability.
Product Sales Overpower Licensing Volatility
The revenue mix is shifting favorably. While Licensing, Royalty, and Patent revenue is Reversing—plummeting 63% YoY to just $0.8M—MRAM Product Sales are Accelerating, jumping 28% YoY to $14.1M. Replacing lumpy project revenue with sticky, recurring product volume is a massive net positive for earnings predictability.
Microchip Foundry Services Execution
Management highlighted ongoing capital execution against a recently signed Foundry Services Agreement with Microchip. This partnership expands Everspin's ecosystem integration, potentially cementing its technology into Microchip's broader defense and industrial microcontroller platforms.
Other KPIs
Stable and slightly Accelerating. Gross margin improved from 51.4% a year ago and 50.8% in the prior quarter. This is impressive given the sharp drop in high-margin licensing revenue, indicating that unit economics on core MRAM product sales are strengthening as volumes scale.
Decelerating. Cash balances dropped by $4.0M sequentially from $44.5M at year-end 2025. The decline was largely driven by $4.4M in property and equipment purchases as the company invests capital to execute the Microchip foundry agreement and scale production.
Guidance
Accelerating. The $16.0M midpoint represents a 21% YoY growth rate compared to $13.2M in Q2 2025. This proves that Q1's momentum is structural, even before factoring in the newly announced $40M defense contract, which is explicitly excluded from this outlook.
Decelerating. This is a severe step down from Q1 2026's $(0.01) and Q2 2025's $(0.03). This heavy GAAP loss guidance suggests that the litigation costs seen in Q1, or aggressive operational ramp-up expenses tied to new contracts, will persist into the next quarter.
Key Questions
Litigation Visibility
You recorded a $1.6M litigation charge this quarter and Q2 GAAP loss guidance is surprisingly wide. Can you detail the nature of this litigation, your total expected exposure, and whether these elevated legal costs are baked into the Q2 guidance?
$40M Defense Contract Mechanics
Regarding the $40M SOTA MRAM US prime contractor award, how should we think about the revenue recognition timeline? Will this primarily act as lumpy engineering services revenue or a steady structural uplift over several years?
Microchip Foundry Capex Needs
Cash decreased by $4M sequentially largely due to CapEx to support the Microchip Foundry Services Agreement. What is the total expected capital intensity required to fulfill this agreement, and when will it transition to being cash flow positive?
NOR Flash Replacement Traction
In prior quarters, you discussed a major opportunity to replace NOR flash due to industry capacity constraints. Are you seeing material conversions of these design wins into the accelerating product sales numbers reported this quarter?